Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease
- 1 April 1994
- journal article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 6 (4), 333-334
- https://doi.org/10.1038/ng0494-333
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The leukodystrophies: a window to myelinNature Genetics, 1993
- Charcot-Marie-Tooth Disease Type 1A -- Association with a Spontaneous Point Mutation in the PMP22 GeneNew England Journal of Medicine, 1993
- Trisomy 17p associated with Charcot‐Marie‐Tooth neuropathy type 1A phenotypeNeurology, 1992
- Peripheral myelin protein–22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot–Marie–Tooth 1ANature Genetics, 1992
- The peripheral myelin protein gene PMP–22 is contained within the Charcot–Marie–Tooth disease type 1A duplicationNature Genetics, 1992
- The peripheral myelin gene PMP–22/GAS–3 is duplicated in Charcot–Marie–Tooth disease type 1ANature Genetics, 1992
- Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid.Proceedings of the National Academy of Sciences of the United States of America, 1991
- A new mutation in the proteolipid protein (PLP) gene in a German family with pelizaeus‐merzbacher diseaseAmerican Journal of Medical Genetics, 1991
- Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder.Proceedings of the National Academy of Sciences of the United States of America, 1989
- An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 regionHuman Genetics, 1987